KUSH PARMAR - 09 Jul 2025 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Signature
/s/ Kush Parmar
Issuer symbol
TRDA
Transactions as of
09 Jul 2025
Transactions value $
-$202,554
Form type
4
Filing time
11 Jul 2025, 17:27:03 UTC
Previous filing
01 Jul 2025
Next filing
18 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PARMAR KUSH Director, 10%+ Owner C/O 5AM VENTURE MANAGEMENT, LLC, 4 EMBARCADERO CENTER, SUITE 3110, SAN FRANCISCO /s/ Kush Parmar 11 Jul 2025 0001664281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRDA Common Stock Sale -$151K -20.1K -0.63% $7.50 3.16M 09 Jul 2025 By 5AM Ventures V, L.P. F1
transaction TRDA Common Stock Sale -$52K -6.94K -0.63% $7.50 1.09M 09 Jul 2025 By 5AM Opportunities I, L.P. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Kush M. Parmar, M.D., Ph.D. is a managing member of 5AM Partners and may be deemed to share voting and investment power over the shares held by 5AM V. Dr. Parmar disclaims beneficial ownership of the shares held by 5AM V except to the extent of his pecuniary interest therein.
F2 Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Kush M. Parmar, M.D., Ph.D. is a managing member of Opportunities GP and may be deemed to share voting and investment power over the shares held by Opportunities. Dr. Parmar disclaims beneficial ownership of the shares held by Opportunities except to the extent of his pecuniary interest therein.